European Journal of Dermatology
MENUWhat's new this month? Volume 29, issue 6, November-December 2019
Authors
1 Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany
2 Department of Dermatology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, United Kingdom
3 Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
4 Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
5 Department of Dermatology, Centro Hospitalar Universitáriodo Porto, Porto, Portugal
- DOI : 10.1684/ejd.2019.3689
- Page(s) : 673-4
- Published in: 2019
In this issue of the European Journal of Dermatology, Hossein Zadeh Attar and colleagues investigated the value of the CD63 basophil activation test (BAT) as a diagnostic tool for assessing autoimmunity in patients with chronic spontaneous urticaria (CSU) [1]. Over the past years, it has become widely recognized based on experimental and clinical evidence that a proportion of CSU cases are of an autoimmune nature. However, an autologous serum skin test (ASST) result alone is not enough for a diagnosis [...]